AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 145 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $720,000 | +5.4% | 47,605 | -36.6% | 0.01% | 0.0% |
| Q1 2022 | $683,000 | +10.5% | 75,097 | -14.7% | 0.01% | +50.0% |
| Q4 2021 | $618,000 | +175.9% | 88,055 | +347.7% | 0.01% | +100.0% |
| Q3 2021 | $224,000 | -64.2% | 19,667 | -49.7% | 0.00% | -57.1% |
| Q2 2021 | $626,000 | +11.0% | 39,086 | +23.9% | 0.01% | -12.5% |
| Q1 2021 | $564,000 | +41.4% | 31,559 | +16.8% | 0.01% | -20.0% |
| Q2 2020 | $399,000 | +5.6% | 27,013 | +37.5% | 0.01% | -23.1% |
| Q3 2019 | $378,000 | -26.6% | 19,642 | +12.7% | 0.01% | -35.0% |
| Q2 2019 | $515,000 | – | 17,421 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |